Tumor necrosis factor primes hepatocytes for DNA replication in the rat

Eric M. Webber, Jordi Bruix, Robert H. Pierce, Nelson Fausto – 30 December 2003 – Signaling through tumor necrosis factor receptor type 1 (TNFR‐1) using a pathway that involves nuclear factor κB (NF‐κB), interleukin‐6 (IL‐6), and STAT3 is required for the initiation of liver regeneration. We have proposed that TNF primes hepatocytes to respond to the mitogenic effect of growth factors, but so far, there has been no experimental demonstration that TNF enhances growth factor responses of hepatocytes.

Interleukin‐6, hepatocyte growth factor, and their receptors in biliary epithelial cells during a type i ductular reaction in mice: Interactions between the periductal inflammatory and stromal cells and the biliary epithelium

Zejin Liu, Toshiki Sakamoto, Tsukasa Ezure, Shigeki Yokomuro, Noriko Murase, George Michalopoulos, Anthony J. Demetris – 30 December 2003 – The interleukin‐6 (IL‐6)/gp‐80 and hepatocyte growth factor (HGF)/met ligand/receptor systems have been shown to stimulate biliary epithelial cell (BEC) DNA synthesis in vitro. The mRNA and protein production of these two in vitro mitogens were mapped in vivo during the first week after bile duct ligation (BDL) when peak BEC DNA synthesis is seen.

Release of osmolytes from perfused rat liver on perivascular nerve stimulation: α‐adrenergic control of osmolyte efflux from parenchymal and nonparenchymal liver cells

Stephan Vom Dahl, Johannes Georg Bode, Roland Michael Reinehr, Irmhild Mönnighoff, Ralf Kubitz, Dieter Häussinger – 30 December 2003 – The effects of perivascular nerve stimulation and phenylephrine on osmolyte release were studied in the intact perfused rat liver and isolated liver parenchymal cells (PC) and nonparenchymal cells.

Kinetics of hepatitis B surface antigen–specific immune responses in acute and chronic hepatitis B or After HBs vaccination: Stimulation of the in vitro antibody response by interferon gamma

Wulf Otto Böcher, Sabine Herzog‐Hauff, Jörg Schlaak, Karl‐Hermann Meyer zum Büschenfelde, Hanns Friedrich Löhr – 30 December 2003 – Because cellular and humoral immune responses against the hepatitis B virus (HBV) surface antigen (HBs) might be crucial to overcome HBV infection, HBs‐specific B‐ and T‐cell responses of HBV patients and HBs vaccine recipients were analyzed quantitatively and functionally.

Reduction of health‐related quality of life in chronic hepatitis C and improvement with interferon therapy

Herbert L. Bonkovsky, J. Michael Woolley – 30 December 2003 – The natural history, prognosis, and clinical significance of chronic hepatitis C are highly variable and somewhat controversial. The purpose of this study was to evaluate the effect of chronic hepatitis C infection on patients' perceptions of health‐related quality of life (HRQOL) and to evaluate whether treatment with interferon improves HRQOL.

Subscribe to